Flexion Therapeutics Inc (OQ:FLXN)

Business Focus: Bio Therapeutic Drugs

Latest 10 SEC filings (by transaction date) for FLXN within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 24th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 24/19 May 23/19 Merrifield C Ann Direct Ownership Common Stock P - Open market or private purchase 8,000 $12.64
May 15/19 May 13/19 Arkowitz David Direct Ownership Common Stock P - Open market or private purchase 4,000 $11.99
May 13/19 May 10/19 Clayman Michael D. Direct Ownership Common Stock P - Open market or private purchase 4,012 $12.48
May 9/19 May 8/19 Arkowitz David Direct Ownership Common Stock S - Open market or private sale -2,248 $10.06
Mar 13/19 Mar 12/19 Clayman Michael D. Direct Ownership Common Stock P - Open market or private purchase 4,046 $12.36
Mar 5/19 Mar 1/19 Wentworth Kerry Direct Ownership Stock option (right to buy) A - Grant, award or other under Rule 16b-3(d) 18,000  
Mar 5/19 Mar 1/19 Wentworth Kerry Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 36,000  
Mar 5/19 Mar 1/19 Kelley Scott Direct Ownership Stock option (right to buy) A - Grant, award or other under Rule 16b-3(d) 18,000  
Mar 5/19 Mar 1/19 Kelley Scott Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 36,000  
Mar 5/19 Mar 1/19 Willwerth Christina Direct Ownership Stock option (right to buy) A - Grant, award or other under Rule 16b-3(d) 18,000  
Sign up for a free account or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for FLXN within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 24th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 24/19 May 23/19 Merrifield C Ann Direct Ownership Common Stock P - Open market or private purchase 8,000 $12.64
May 15/19 May 13/19 Arkowitz David Direct Ownership Common Stock P - Open market or private purchase 4,000 $11.99
May 13/19 May 10/19 Clayman Michael D. Direct Ownership Common Stock P - Open market or private purchase 4,012 $12.48
May 9/19 May 8/19 Arkowitz David Direct Ownership Common Stock S - Open market or private sale -2,248 $10.06
Mar 13/19 Mar 12/19 Clayman Michael D. Direct Ownership Common Stock P - Open market or private purchase 4,046 $12.36
Mar 5/19 Oct 6/18 Wentworth Kerry Direct Ownership Restricted Stock Unit Award M - Exercise or conversion exempt under rule 16b-3 -3,400  
Mar 5/19 Oct 8/18 Wentworth Kerry Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -1,002 $18.60
Mar 5/19 Oct 6/18 Wentworth Kerry Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 3,400  
Mar 5/19 Mar 1/19 Wentworth Kerry Direct Ownership Stock option (right to buy) A - Grant, award or other under Rule 16b-3(d) 18,000  
Mar 5/19 Mar 1/19 Wentworth Kerry Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 36,000  
Sign up for a free account or login above to see all SEC filings within the past 6 months.
Sign up for a free account or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now
Comment On!
140

Twitter

Search (past week) for $FLXN

StockTwits